IL102407A - Use of acylates of non-methylated pyrimidine nucleosides in medicaments for preventing or treating undesirable side-effects in anticancer or antiviral chemotherapy and pharmaceutical compositions containing the acylates - Google Patents

Use of acylates of non-methylated pyrimidine nucleosides in medicaments for preventing or treating undesirable side-effects in anticancer or antiviral chemotherapy and pharmaceutical compositions containing the acylates

Info

Publication number
IL102407A
IL102407A IL10240792A IL10240792A IL102407A IL 102407 A IL102407 A IL 102407A IL 10240792 A IL10240792 A IL 10240792A IL 10240792 A IL10240792 A IL 10240792A IL 102407 A IL102407 A IL 102407A
Authority
IL
Israel
Prior art keywords
acylates
anticancer
medicaments
preventing
effects
Prior art date
Application number
IL10240792A
Other versions
IL102407A0 (en
Original Assignee
Pro Neuron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Neuron Inc filed Critical Pro Neuron Inc
Publication of IL102407A0 publication Critical patent/IL102407A0/en
Publication of IL102407A publication Critical patent/IL102407A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
IL10240792A 1991-07-05 1992-07-03 Use of acylates of non-methylated pyrimidine nucleosides in medicaments for preventing or treating undesirable side-effects in anticancer or antiviral chemotherapy and pharmaceutical compositions containing the acylates IL102407A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72434091A 1991-07-05 1991-07-05
US90310792A 1992-06-25 1992-06-25

Publications (2)

Publication Number Publication Date
IL102407A0 IL102407A0 (en) 1993-01-14
IL102407A true IL102407A (en) 1997-01-10

Family

ID=27110963

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10240792A IL102407A (en) 1991-07-05 1992-07-03 Use of acylates of non-methylated pyrimidine nucleosides in medicaments for preventing or treating undesirable side-effects in anticancer or antiviral chemotherapy and pharmaceutical compositions containing the acylates

Country Status (3)

Country Link
CN (1) CN1050996C (en)
IL (1) IL102407A (en)
MX (1) MX9203963A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100502891C (en) * 2005-12-09 2009-06-24 中国科学院化学研究所 Use of gekko powder for preparing medicine for treating colon adenocarcinoma
CA2729613C (en) * 2008-03-03 2017-02-07 Tosk, Incorporated Methotrexate adjuvants to reduce toxicity and methods for using the same
EP2649879A1 (en) 2012-04-10 2013-10-16 Basf Se Pesticidal mixtures containing fluxapyroxad
WO2013156331A1 (en) 2012-04-16 2013-10-24 Basf Se Synergistic compositions comprising pyraclostrobin and an insecticidal compound
JP2018509165A (en) * 2015-03-19 2018-04-05 インスティトゥト、ウニベルシタット、デ、シエンシア、イ、テクノロヒア、ソシエダ、アノニマＩｎｓｔｉｔｕｔ Ｕｎｉｖ． Ｄｅ Ｃｉｅｎｃｉａ Ｉ Ｔｅｃｎｏｌｏｇｉａ，Ｓ．Ａ． Deamination of organophosphate nucleosides
CN107875165B (en) * 2017-11-19 2018-09-04 宋在明 A kind of Percutaneously administrable preparation for treating bone marrow suppression caused by tumour radiotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100478A1 (en) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ESTERS OF PYRIMIDINE NUCLEOSIDES WITH ANTIVIRAL EFFECTIVENESS, METHOD FOR THE PRODUCTION AND MEDICINAL PRODUCTS THEREOF
DE3481191D1 (en) * 1983-07-20 1990-03-08 Teijin Ltd ANTINEOPLASTIC AGENT.

Also Published As

Publication number Publication date
CN1050996C (en) 2000-04-05
MX9203963A (en) 1993-04-01
CN1071577A (en) 1993-05-05
IL102407A0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
GR3032299T3 (en) Antiviral nucleoside combination.
GB2194880B (en) Adjustable shelf organizer units having frangible side and rear portions
PH25932A (en) Adenosine derivatives and pharmaceutical compositions containing the same
NZ262797A (en) Polycyclic guanine derivatives, purine and pyrimidine precursors; medicaments
NZ225542A (en) Avermectin derivatives and parasiticidal compositions
IL110992A0 (en) n-substituted 5'-deoxy adenosine derivatives and pharmaceutical compositions containing them
CA2504078A1 (en) Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
EP0409227A3 (en) Pyrimidine and purine nucleosides, their preparation and use as medicaments
IL105673A0 (en) Purine derivatives and pharmaceutical compositions containing them
IL105672A0 (en) Substituted adenosine derivatives and pharmaceutical compositions containing them
HK1002426A1 (en) Use of dideoxy nucleoside analogues in the treatment of viral infections
IL103513A0 (en) 2,6-disubstituted purine derivatives,their preparation and pharmaceutical compositions containing them
IL108119A0 (en) Purine derivatives their preparation and pharmaceutical compositions containing them
IL102407A (en) Use of acylates of non-methylated pyrimidine nucleosides in medicaments for preventing or treating undesirable side-effects in anticancer or antiviral chemotherapy and pharmaceutical compositions containing the acylates
EP0642347A4 (en) Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia.
PL299412A1 (en) Novel purine nucleosides, novel intermediate compounds and pharmaceutical preparation
IL92587A0 (en) 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
NZ331088A (en) Method for inhibiting adenylosuccinate synthetase activity methylthioadenosine phosphorylase deficient cells
HU9403021D0 (en) 7-disubstituted-methyl-4-oxo-3h,5h-pyrrolo[3,2-d]pyrimidine and pharmaceutical compositions containing them
IL91356A0 (en) Therapeutic nucleosides,their preparation and pharmaceutical compositions containing them
NZ219971A (en) Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions
NZ219250A (en) Purine derivatives and pharmaceutical compositions
NZ214616A (en) Pharmaceutical compositions containing uridine-diphosphoglucose(udpg)
IL104306A0 (en) Nucleosides,their preparation and pharmaceutical compositions containing them
IL90863A0 (en) Annelated indoleketones with an imidazolylalkyl substituent,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired